Navigation Links
New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis
Date:6/12/2008

patients with moderate to severe RA with inadequate

response to MTX, including assessment of inhibition of radiographic

progression.

* The STAR trial: a Phase III study that evaluated the efficacy and

safety of HUMIRA when added to a standard treatment regimen for RA

in patients with inadequate response.

* DE005: a Phase I study evaluating the safety and efficacy of HUMIRA

in combination with methotrexate in methotrexate partial responders.

* DE037: a Phase I roll-over study that evaluated the safety,

pharmacokinetics and early signs of HUMIRA efficacy among RA

patients in the United States and Japan.

Efficacy

* After six months of therapy, all efficacy measures showed

significant improvements versus baseline.

* At year two, additional improvements were observed in American

College of Rheumatology (ACR) responses. ACR responses represent a

percent improvement in tender joint count, swollen joint count and

other relevant clinical measures.

* Improved response after year one was confirmed by examining

sustained clinical remission (Disease Activity Score (DAS28) of less

than 2.6) for at least three consecutive visits; sustained remission

was achieved in 42 percent of all patients after a mean of 18 +/- 17

months. DAS28 is a composite index that includes variables such as

the number of tender and swollen joints, specific laboratory values

and other measures of disease activity.

Safety

* The treatment exposure-adjusted rate of serious adverse events

(SAEs), and serious infections, declined progressively during seven

years of observation.

* Rates and types of SAEs were consistent with randomized controlled

trials, including the rate of se
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Smoking may strongly increase long-term risk of eye disease
2. Long-Term Fatigue Plagues Cancer Survivors
3. Dont Ignore Tough or Long-Term Stomach Pain
4. Shaking may cause brain damage and serious long-term effects to infants
5. Sexual function affected by stem cell transplant according to long-term study
6. Smoking can harm the long-term effects of some oral surgery procedures
7. Childhood Obesity Epidemic a Long-Term Challenge
8. Conseco to Host Follow-Up Long-Term Care Conference Call
9. New Report Finds Information Technology Essential But Not Sufficient in Long-Term Care
10. No Link Between Amateur Boxing, Long-Term Brain Damage
11. No strong evidence linking amateur boxing with long-term brain injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014 Follow us on ... the medical imaging market, are engineered to enhance the ... the past three decades have expanded the application roles ... iodine based agents used for over half a century ... imaging agents have witnessed sea changes, revolutionizing in the ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 ... ligand assays used for detection and quantification of ... given sample. Driven by steady expansion in immunodiagnostics ... the global immunoassay systems market has evolved remarkably ... conditions, such as diabetes, cardio-vascular ailments, infectious diseases, ...
(Date:9/19/2014)... September 19, 2014 The ... traditional Scandinavian style of eating, is making ... like Diet Doc’s medical weight loss ... and eating good food which leads to ... on teaching patients to understand how diet ...
(Date:9/19/2014)... September 19, 2014 The Relaxation ... years to 2014. Industry operators were able to mass ... period, as well as establish distribution contracts with nation-wide ... large part to its novelty; energy drinks have only ... time, industry operators have been able to establish brands ...
(Date:9/19/2014)... 19, 2014 Recent financial data ... industry increased their sales by 7% in the last ... trucking industry can be used as a bellwether to ... whole. This data has been proven to show trends ... freight transportation. Other non-trucking data is largely influenced by ...
Breaking Medicine News(10 mins):Health News:New Clinical Applications and Advanced Imaging Capabilities Drive Growth in the Imaging Agents Market, According to New Report by Global Industry Analysts, Inc. 2Health News:New Clinical Applications and Advanced Imaging Capabilities Drive Growth in the Imaging Agents Market, According to New Report by Global Industry Analysts, Inc. 3Health News:New Clinical Applications and Advanced Imaging Capabilities Drive Growth in the Imaging Agents Market, According to New Report by Global Industry Analysts, Inc. 4Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 4Health News:Diet Doc’s Medical Weight Loss Programs Announce Diet Plans Based on the Same Principles as the New Nordic Diet 2Health News:Diet Doc’s Medical Weight Loss Programs Announce Diet Plans Based on the Same Principles as the New Nordic Diet 3Health News:Diet Doc’s Medical Weight Loss Programs Announce Diet Plans Based on the Same Principles as the New Nordic Diet 4Health News:Relaxation Drink Production in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Relaxation Drink Production in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:LeaseQ Announces Good News For The Truck Leasing Industry As Truck Rentals In The U.S Continues to Gain Traction 2Health News:LeaseQ Announces Good News For The Truck Leasing Industry As Truck Rentals In The U.S Continues to Gain Traction 3
... If war is too serious a matter to be left in ... be left to the care of labour department officials. At least ... ,Latest trends show that agencies like the Occupational Safety and ... of the industries than with the safety of the workers themselves. ...
... Despite being safe, anti-anginal medication Ranolazine has not been ... such as death// , heart attack or recurrent ischemia ... the treatment of acute coronary syndromes (ACS), the risk ... used for patients with chronic angina, but because of ...
... the body’s genetic repair system may cause Huntington’s disease, ... destroying their nervous system. Until now, no one knew ... ,"We showed that when single-strand breaks in DNA ... continued to add extra replacement segments," explains Cynthia McMurray, ...
... Center have zeroed in on a crucial gene, thought ... cancer and resistance// to long-term estrogen deprivation. The gene ... breast cancer reappearance, and would enable a good idea ... ,The research targeted breast cancer cells which had ...
... sentence is being questioned. A study by Plos medicine reveal that ... by the UK based Lancet in 2005. ,This injection ... federal government but many have put a stop to it as ... one drug to induce sleep, the second to stop breathing and ...
... die due to cancer every day, Health Minister Anbumani Ramadoss ... cases in the country were due to tobacco consumption. ... are due to tobacco. The relationship between oral cancer and ... which 91 percent of oral cancers in Southeast Asia are ...
Cached Medicine News:Health News:Overseeing Agency Indifferent to Workplace Safety in US 2Health News:Anti-anginal Drug Not Effective in Reducing Major Cardiac Events 2Health News:Researchers Discovers DNA Repair as Key to Huntington's Disease 2Health News:Execution by Lethal Injection Questioned 2
(Date:9/19/2014)... Mich. , Sept. 19, 2014  Diplomat, the ... of David Dreyer to the Board of ... independent director and will also serve as chair of ... almost 30 years of accounting, financial, compliance and operating ... Mr. Dreyer has served as chief financial officer, chief ...
(Date:9/19/2014)... , Sept. 19, 2014 UBM Medica ... a leading online community to help oncologists and other ... available regarding the use of targeted therapies and immunotherapies, ... research and treatment.  Every September, ... way to raise awareness about blood cancers—helping to increase ...
(Date:9/19/2014)... 2014 Five MinuteClinic walk-in medical clinics are opening inside ... area. Three clinics opened in Memphis and ... will be added in Springfield on September ... is expected to open October 22.  MinuteClinic is the largest and ... United States . The Memphis ...
Breaking Medicine Technology:David Dreyer Appointed to Diplomat Board of Directors 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3
... , , , , , , , , , ... and LAUSANNE, Switzerland , February 4 ... Debiopharm Group (Debiopharm), a Swiss-based global,biopharmaceutical group of companies with ... medical needs, announce the launch by,Ipsen in France ...
... , REDWOOD CITY, Calif. , Feb. ... financial results for the year ended December 31, 2009 , which ... cash flow positive. , Total revenue for the fourth quarter of 2009 ... in the fourth quarter of 2008.  Product revenue from the Onco type ...
Cached Medicine Technology:Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 2Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 3Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 4Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 5Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer 6Genomic Health Announces Year-End 2009 Financial Results 2Genomic Health Announces Year-End 2009 Financial Results 3Genomic Health Announces Year-End 2009 Financial Results 4Genomic Health Announces Year-End 2009 Financial Results 5Genomic Health Announces Year-End 2009 Financial Results 6Genomic Health Announces Year-End 2009 Financial Results 7Genomic Health Announces Year-End 2009 Financial Results 8Genomic Health Announces Year-End 2009 Financial Results 9Genomic Health Announces Year-End 2009 Financial Results 10Genomic Health Announces Year-End 2009 Financial Results 11Genomic Health Announces Year-End 2009 Financial Results 12
Adjustable lid speculum angled 45 degrees with 17 mm curved solid blades and aspiration ports to remove excess fluid from around the eye during ocular procedures....
Open 11 mm blades. Dull finish. Most popular size or model....
Open 15 mm blades with lifting wings manipulation of I/A cannulas, knives, instrumentation, etc. Screwlocking mechanism. Dull finish....
Angled for temporal approach. Solid 14 mm blades. Dull finish....
Medicine Products: